Ingevity (NGVT) Stock Price, News & Analysis

Company Overview

Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. The company develops products designed to improve environmental performance, enhance infrastructure and support industrial manufacturing.

Ingevity’s products include activated carbon technologies used in automotive evaporative-emissions control systems, as well as applications involving air and water purification. The company also produces specialty chemicals and materials used in pavement preservation, asphalt modification and other industrial applications. Its road technologies are designed to extend pavement life and improve the performance of transportation infrastructure.

Ingevity was established as an independent public company in 2016 following its separation from WestRock, although its operations draw on a longer history associated with the former MeadWestvaco specialty chemicals business. The company serves customers in North America, Europe, Asia and other international markets through manufacturing, research and commercial operations in multiple regions.

Key Stats

• Today's Range: $72.04 to $73.65
• 50-Day Range: $66.95 to $77.79
• 52-Week Range: $45.85 to $79.29
• Volume: 178,597 shs
• Average Volume: 263,011 shs
• Market Capitalization: $2.49 billion
• P/E Ratio: 49.26
• Dividend Yield: N/A
• Price Target: $80.00
• Consensus Rating: Hold

Ingevity Stock Analysis - MarketRank™

Ingevity scored higher than 40% of companies evaluated by MarketBeat, and ranked 180th out of 231 stocks in the materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.2 / 5
• Analyst Rating: Hold

Consensus Rating

Ingevity has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Ingevity has a consensus price target of $80.00, representing about 10.5% upside from its current price of $72.41.

Amount of Analyst Coverage

Ingevity has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.26%

Earnings Growth

Earnings for Ingevity are expected to grow by 9.26% in the coming year, from $5.40 to $5.90 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Ingevity is 49.26, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ingevity is 49.26, which means that it is trading at a more expensive P/E ratio than the Materials sector average P/E ratio of about 24.97.

Price to Book Value per Share Ratio

Ingevity has a P/B Ratio of 87.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.24% of the float of Ingevity has been sold short.

Short Interest Ratio / Days to Cover

Ingevity has a short interest ratio ("days to cover") of 6.09.

Change versus previous month

Short interest in Ingevity has recently increased by 9.68%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ingevity does not currently pay a dividend.

Dividend Growth

Ingevity does not have a long track record of dividend growth.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: N/A

News Sentiment

Ingevity has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Materials companies.

MarketBeat Follows

1 people have added Ingevity to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Ingevity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,347,481.00 in company stock.

Percentage Held by Insiders

0.88% of the stock of Ingevity is held by insiders.

Percentage Held by Institutions

91.59% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 10/04/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Materials
• Industry: Chemicals
• Sub-Industry: Specialty Chemicals
• Current Symbol: NYSE:NGVT
• Previous Symbol: NASDAQ:NGVT
• CIK: 1653477
• Web: www.ingevity.com
• Phone: (843) 740-2300
• Fax: 843-740-8165
• Employees: 1,500
• Year Founded: 2015

Price Target and Rating

• Average Price Target for Ingevity: $80.00
• High Price Target: $83.00
• Low Price Target: $75.00
• Potential Upside/Downside: +10.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.47
• Trailing P/E Ratio: 49.26
• Forward P/E Ratio: 13.41
• P/E Growth: N/A
• Net Income: -$167.10 million
• Net Margins: 4.65%
• Pretax Margin: 3.26%
• Return on Equity: 284.70%
• Return on Assets: 10.82%

Debt

• Debt-to-Equity Ratio: 22.52
• Current Ratio: 1.61
• Quick Ratio: 1.15

Sales & Book Value

• Annual Sales: $1.17 billion
• Price / Sales: 2.13
• Cash Flow: $12.27 per share
• Price / Cash Flow: 5.90
• Book Value: $0.83 per share
• Price / Book: 87.23

Miscellaneous

• Outstanding Shares: 34,380,000
• Free Float: 34,075,000
• Market Cap: $2.49 billion
• Optionable: Optionable
• Beta: 1.14